publicações selecionadas
-
artigo académico
-
artigo de conferência
-
documento
- Molecular docking reveals CDK1 as a therapeutic target of novel purine derivatives in triple negative breast cancer 2025
- Smart extracellular vesicles for targeted therapy in breast cancer 2025
- Smart extracellular vesicles for targeted therapy in breast cancer. 2025
- In vitro assessment and mechanism of action of novel purine derivatives as anticancer agents 2024
- Derivados de purina: opções terapêuticas contra o cancro de mama triplo negativo 2024
- Unveiling the anticancer potential of 6-hydrazinopurines 2024
- Exploring the potential of new 6-hydrazinopurine as effective anticancer agents 2023
- In vitro assessment of 6-hydrazinopurines as anticancer agents 2022
-
teses